BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29663992)

  • 21. Diagnostic utility of lactate dehydrogenase levels in patients receiving aerosolized pentamidine.
    Meeker DP; Matysik GA; Stelmach K; Rehm S
    Chest; 1993 Aug; 104(2):386-8. PubMed ID: 8339623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic indicators in the initial presentation of Pneumocystis carinii pneumonia.
    Garay SM; Greene J
    Chest; 1989 Apr; 95(4):769-72. PubMed ID: 2784372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics and diagnosis of Pneumocystis carinii pneumonia (PCP) in patients with the acquired immunodeficiency syndrome (AIDS)].
    Zhang K; Ma D; Xu B; Zhao D; Wu H; Hua L; Qin S; Xu L
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):475-7. PubMed ID: 12425833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia.
    Vogel M; Weissgerber P; Goeppert B; Hetzel J; Vatlach M; Claussen C; Horger M
    Swiss Med Wkly; 2011; 141():w13184. PubMed ID: 21528464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.
    Schmidt JJ; Lueck C; Ziesing S; Stoll M; Haller H; Gottlieb J; Eder M; Welte T; Hoeper MM; Scherag A; David S
    Crit Care; 2018 Nov; 22(1):307. PubMed ID: 30454031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of the LDH level in pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus].
    Boudes P; Furhman C; Verra F; Sobel A
    Ann Med Interne (Paris); 1990; 141(2):175-8. PubMed ID: 2353759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated lactate dehydrogenase values in patients with Pneumocystis carinii pneumonia.
    Smith RL; Ripps CS; Lewis ML
    Chest; 1988 May; 93(5):987-92. PubMed ID: 3258807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study.
    Zeng YM; Li Y; Lu YQ; Liu M; Nie JM; Yuan J; Harypursat V; Zhou YH; Qin YY; Chen XH; Zhang YL; Zhang DF; Wang N; Chen H; Tian Q; Zhou Y; Qin YM; Yang XP; Chen YK
    BMC Pulm Med; 2022 Aug; 22(1):323. PubMed ID: 36008855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Pilot Study of Echinocandin Combination with Trimethoprim/Sulfamethoxazole and Clindamycin for the Treatment of AIDS Patients with Pneumocystis Pneumonia.
    Wang M; Lang G; Chen Y; Hu C; Guo Y; Tao R; Dong X; Zhu B
    J Immunol Res; 2019; 2019():8105075. PubMed ID: 31886310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of serum lactate dehydrogenase level with selected opportunistic infections and HIV progression.
    Butt AA; Michaels S; Kissinger P
    Int J Infect Dis; 2002 Sep; 6(3):178-81. PubMed ID: 12718831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis carinii pneumonia in HIV infected patients: effects of the diseases on glutathione and glutathione disulfide.
    Adams JD; Jaresko GS; Louie SG; Klaidman LK; Kennedy D; Sharma O; Boylen CT
    J Med; 1993; 24(6):337-52. PubMed ID: 8182348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Model to Predict In-Hospital Mortality in HIV/AIDS Patients with Pneumocystis Pneumonia in China: The Clinical Practice in Real World.
    Wu L; Zhang Z; Wang Y; Hao Y; Wang F; Gao G; Yang D; Xiao J; Zhao H
    Biomed Res Int; 2019; 2019():6057028. PubMed ID: 30906778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumocystis carinii pneumonia in Malawian children.
    Kamiya Y; Mtitimila E; Graham SM; Broadhead RL; Brabin B; Hart CA
    Ann Trop Paediatr; 1997 Jun; 17(2):121-6. PubMed ID: 9230974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum indicators for the diagnosis of pneumocystis pneumonia.
    Tasaka S; Hasegawa N; Kobayashi S; Yamada W; Nishimura T; Takeuchi T; Ishizaka A
    Chest; 2007 Apr; 131(4):1173-80. PubMed ID: 17426225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.
    Zhu M; Ye N; Xu J
    PLoS One; 2020; 15(9):e0238184. PubMed ID: 32911508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lactic dehydrogenase predicts mortality in patients with AIDS and Pneumocystis pneumonia.
    Lipman ML; Goldstein E
    West J Med; 1988 Oct; 149(4):486-7. PubMed ID: 3265825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J; Rubio García R; Antela López A; García Alcaide F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on risk factors of short-term outcome in AIDS patients with pneumocystis pneumonia].
    Li AX; Huang CY; Zhang HW; Zhang T; Wu H; Wang W
    Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(11):833-837. PubMed ID: 28355738
    [No Abstract]   [Full Text] [Related]  

  • 40. Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.
    Wood BR; Komarow L; Zolopa AR; Finkelman MA; Powderly WG; Sax PE
    AIDS; 2013 Mar; 27(6):967-972. PubMed ID: 23698062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.